Cargando…
Advances and Prospects in the Treatment of Pancreatic Cancer
Pancreatic cancer is a highly malignant and incurable disease, characterized by its aggressive nature and high fatality rate. The most common type is pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis and high mortality rate. Current treatments for pancreatic cancer mainly encompass s...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363367/ https://www.ncbi.nlm.nih.gov/pubmed/37489138 http://dx.doi.org/10.2147/IJN.S413496 |
_version_ | 1785076610740781056 |
---|---|
author | Duan, Huaiyu Li, Li He, Shiming |
author_facet | Duan, Huaiyu Li, Li He, Shiming |
author_sort | Duan, Huaiyu |
collection | PubMed |
description | Pancreatic cancer is a highly malignant and incurable disease, characterized by its aggressive nature and high fatality rate. The most common type is pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis and high mortality rate. Current treatments for pancreatic cancer mainly encompass surgery, chemotherapy, radiotherapy, targeted therapy, and combination regimens. However, despite efforts to improve prognosis, and the 5-year survival rate for pancreatic cancer remains very low. Therefore, it’s urgent to explore novel therapeutic approaches. With the rapid development of therapeutic strategies in recent years, new ideas have been provided for treating pancreatic cancer. This review expositions the advancements in nano drug delivery system, molecular targeted drugs, and photo-thermal treatment combined with nanotechnology for pancreatic cancer. It comprehensively analyzes the prospects of combined drug delivery strategies for treating pancreatic cancer, aiming at a deeper understanding of the existing drugs and therapeutic approaches, promoting the development of new therapeutic drugs, and attempting to enhance the therapeutic effect for patients with this disease. |
format | Online Article Text |
id | pubmed-10363367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-103633672023-07-24 Advances and Prospects in the Treatment of Pancreatic Cancer Duan, Huaiyu Li, Li He, Shiming Int J Nanomedicine Review Pancreatic cancer is a highly malignant and incurable disease, characterized by its aggressive nature and high fatality rate. The most common type is pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis and high mortality rate. Current treatments for pancreatic cancer mainly encompass surgery, chemotherapy, radiotherapy, targeted therapy, and combination regimens. However, despite efforts to improve prognosis, and the 5-year survival rate for pancreatic cancer remains very low. Therefore, it’s urgent to explore novel therapeutic approaches. With the rapid development of therapeutic strategies in recent years, new ideas have been provided for treating pancreatic cancer. This review expositions the advancements in nano drug delivery system, molecular targeted drugs, and photo-thermal treatment combined with nanotechnology for pancreatic cancer. It comprehensively analyzes the prospects of combined drug delivery strategies for treating pancreatic cancer, aiming at a deeper understanding of the existing drugs and therapeutic approaches, promoting the development of new therapeutic drugs, and attempting to enhance the therapeutic effect for patients with this disease. Dove 2023-07-19 /pmc/articles/PMC10363367/ /pubmed/37489138 http://dx.doi.org/10.2147/IJN.S413496 Text en © 2023 Duan et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Duan, Huaiyu Li, Li He, Shiming Advances and Prospects in the Treatment of Pancreatic Cancer |
title | Advances and Prospects in the Treatment of Pancreatic Cancer |
title_full | Advances and Prospects in the Treatment of Pancreatic Cancer |
title_fullStr | Advances and Prospects in the Treatment of Pancreatic Cancer |
title_full_unstemmed | Advances and Prospects in the Treatment of Pancreatic Cancer |
title_short | Advances and Prospects in the Treatment of Pancreatic Cancer |
title_sort | advances and prospects in the treatment of pancreatic cancer |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10363367/ https://www.ncbi.nlm.nih.gov/pubmed/37489138 http://dx.doi.org/10.2147/IJN.S413496 |
work_keys_str_mv | AT duanhuaiyu advancesandprospectsinthetreatmentofpancreaticcancer AT lili advancesandprospectsinthetreatmentofpancreaticcancer AT heshiming advancesandprospectsinthetreatmentofpancreaticcancer |